Compounds > ciprofloxacin

ciprofloxacin and ciclopirox

ciprofloxacin has been researched along with ciclopirox in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Carlson-Banning, KM; Chou, A; Hamill, RJ; Liu, Z; Song, Y; Zechiedrich, L1

Other Studies

3 other study(ies) available for ciprofloxacin and ciclopirox

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biosynthetic Pathways; Ciclopirox; Ciprofloxacin; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Galactose; Humans; Hydrogen Peroxide; Iron; Klebsiella pneumoniae; Lipopolysaccharides; Microbial Sensitivity Tests; Microbial Viability; Mutation; Phenotype; Pyridones

2013